Pasithea Therapeutics Corp. Gains 45.05%
Mon, Dec 11, 2023 at 07:11 PM
Pasithea Therapeutics Corp. (KTTA:NASDAQ) soared at $0.44, representing a gain of 45%. On Mon, Dec 11, 2023, KTTA:NASDAQ hit a New 2-Week High of $0.44. The stock appeared on our News Catalysts scanner on Mon, Dec 11, 2023 at 10:49 AM in the 'BIOTECH' category. From Mon, Nov 27, 2023, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Dec 11, 2023 at $0.87 with a volume of 98M+.
About Pasithea Therapeutics Corp. (KTTA:NASDAQ)
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Top 10 Gainers:
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 100%
- JetAI Inc Com (JTAI:NASDAQ), 81.93%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 71.44%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 45.05%
- SaverOne 2014 Ltd. (SVRE:NASDAQ), 45%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 42.73%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 40.13%
- IN8bio Inc. (INAB:NASDAQ), 29.29%
- Innoviz Technologies Ltd. (INVZ:NASDAQ), 27.78%
- Surf Air Mobility Inc. (SRFM:NYSE), 27.13%